1h Free Analyst Time
The tissue engineering and regeneration market is forecasted to grow by USD 28.3 billion during 2023-2028, accelerating at a CAGR of 16.86% during the forecast period. The report on the tissue engineering and regeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, rising adoption of tissue scaffolds, and increasing initiatives and support from public and private healthcare organizations for cell-based tissue engineering research.
The tissue engineering and regeneration market is segmented as below:
By Material
- Synthetic
- Biologic
- Genetically modified
By Application
- Orthopedic musculoskeletal and spine
- Dermatology
- Neurology
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the tissue engineering and regeneration market covers the following areas:
- Tissue engineering and regeneration market sizing
- Tissue engineering and regeneration market forecast
- Tissue engineering and regeneration market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Material
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global tissue engineering and regeneration market: 3M Co., AbbVie Inc., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., CO.DON GmbH, Cook Group Inc., Integra Lifesciences Corp., Johnson and Johnson Services Inc., Medtronic Plc, Organogenesis Holdings Inc., Plus Therapeutics Inc., REPROCELL Inc., RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Vericel Corp., and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emerging technological advances."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- AbbVie Inc.
- Astellas Pharma Inc.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- CO.DON GmbH
- Cook Group Inc.
- Integra Lifesciences Corp.
- Johnson and Johnson Services Inc.
- Medtronic Plc
- Organogenesis Holdings Inc.
- PLUS THERAPEUTICS Inc.
- REPROCELL Inc.
- RTI Surgical Inc.
- Smith and Nephew plc
- Stryker Corp.
- Tissue Regenix Group Plc
- Vericel Corp.
- Zimmer Biomet Holdings Inc.
